
The GLP-1 blind spot: Why the FDA’s new eye stroke warning matters
It forces the medical community to treat these therapies with clinical gravity instead of casual enthusiasm.

It forces the medical community to treat these therapies with clinical gravity instead of casual enthusiasm.

The approval culminates a winding development journey for Infilbray, and provides Sanofi with a new source of income ahead of Dupixent’s looming patent expiration.
The product of a collaboration with Alnylam, Livsayis is now Regeneron’s first marketed RNAi drug and will compete against established medicines from AstraZeneca and Argenx.

Every day of delay has consequences. Women like Herring and their unborn children deserve protection now — not more bureaucratic excuses and endless delays.

"This time requires leadership and fortitude," Senator Bill Cassidy said.

STAT tackles the most important questions about the FDA's uncertain future.

The sudden end of Heidi Overton’s candidacy likely ensures a Democrat-controlled Congress will choose the FDA’s next leader — but shouldn’t disrupt the agency, analysts say.

Sen. Bill Cassidy (R-La.) questioned the Trump administration’s reasoning for pulling Food and Drug Administration (FDA) commissioner nominee Heidi Overton, saying he thought she had the support needed to be confirmed. “Tonight, the White House abandoned a viable confirmation path for Dr. Overton. The WH said that this was because she did not have the...

The FDA published its complete response letter to Summit Therapeutics explaining why it rejected the biotech's closely watched lung cancer drug:

The FDA had several issues with ivonescimab, according to the letter. Elsewhere, Sellas shares rocketed on results for a leukemia vaccine and Biogen and Lilly struck up new R&D pacts.
The White House has dropped the nomination of Dr. Heidi Overton, President Trump's pick for FDA commissioner, CBS News has confirmed.

Move to drop Trump ally and prominent abortion opponent comes a day before key Senate health committee vote The White House has dropped its nomination of Heidi Overton to lead the Food and Drug Administration, a White House official told the Guardian. Donald Trump nominated Overton – a physician and prominent abortion opponent – in August. Overton has spent most of her professional career working directly for Trump or conservative groups aligned with his agenda. Her…

The White House withdrew the nomination of Heidi Overton to lead the Food and Drug Administration (FDA) amid opposition from Senate Republicans, it confirmed to The Hill. Overton was set to face a key vote Wednesday in the Senate health committee, where Republicans hold only a one-vote majority — meaning losing one member would be...

The White House is dropping Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, a White House official confirmed Tuesday.

The White House is dropping Heidi Overton's nomination to lead the Food and Drug Administration because of a lack of congressional support, Axios has learned. Why it matters: The decision means the Trump administration will have to find a new candidate to lead the FDA as HHS Secretary Robert F. Kennedy Jr. looks to advance his Make America Healthy Again agenda. "FDA nominee Heidi Overton lacks the support on the Hill to move forward with her confirmation," a senior…
Heidi Overton, Trump's pick to be FDA commissioner, is having trouble finding enough Republican support to advance her nomination, which could be pulled if she falls short.
Wilserdly’s U.S. approval is seen by analysts as a “key first step” in an important launch for Roche, which has claimed the drug could become its top-selling product.

13 Mins ReadUS cultivated meat leader Upside Foods has secured FDA and USDA clearance for its second-generation chicken, which it says is the industry’s first cultivated meat produced at large commercial scale. The halal-certified product, priced on par with premium organic chicken, is now on the menu at eight California restaurants and Stanford University, with chefs Thomas

6 Mins ReadFrench precision fermentation startup Verley has opened a US branch and appointed Shayri Roychoudhury as its new COO as it ramps up production of its cow-free whey proteins for a mid-2027 launch. A year after securing a ‘no questions’ letter from the US Food and Drug Administration (FDA), Verley has now set up a new

The supplement NAC has been widely available for years, but exists in a legal gray area.

The FDA refused to overlook ivonescimab’s failure to initially extend survival in a form of lung cancer, setting back Summit’s first chance to win a U.S. approval.

Shares in Hong Kong-listed Akeso plunged as much as 31.8 per cent on Monday morning after the US Food and Drug Administration (FDA) rejected its cancer drug application, raising investor worries over the company’s near-term commercial outlook. Ivonescimab, one of the most closely watched innovative drugs emerging from China, did not establish “substantial evidence of effectiveness”, said US firm Summit Therapeutics, which has the exclusive rights to develop and commercialise…

Sen. Bill Cassidy (R-La.) on Sunday said there are still questions left unanswered about President Trump's pick to lead the Food and Drug Administration (FDA), Dr. Heidi Overton, ahead of the Senate Health Committee's vote on her nomination this week. "Face the Nation" host Margaret Brennan asked Cassidy, the committee's chair, on CBS News if...

The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the Chinese drugmaker Akeso.

The FDA issues a warning about GLP-1s, a soccer behemoth dumps its head coach, and this year’s Booker prize winner makes history.
Every medication comes with two types of medical facts: indications, which describe what conditions the drug treats (benefits), and contraindications, which describe who must avoid it to prevent serious harm (safety limits). Although contraindications are critical for patient safety and FDA regulations require listing them as rigorously as indications, we find that contraindications are far less documented than indications in general prose. In this paper, we measure how…

"The recall was initiated after FDA laboratory testing identified undeclared tadalafil," the notice said.

The FDA is set to finish its safety review of the abortion pill mifepristone in March, setting up one of the most politically charged decisions the agency has faced in years.

The agency is still recovering from a mass staff exodus last year that left it shorthanded. Here’s what it means for the industry.
Nature Biotechnology, Published online: 12 November 2026; doi:10.1038/s41587-026-03378-9 An analysis of Investigational New Drug (IND) submissions to the US Food and Drug Administration (FDA) from 1995 to 2025 reveals a rapid growth in adeno-associated virus (AAV) development over three decades and highlights common reasons for regulatory holds that should be considered for successful product development.